Medicine Development and Access for Rare Diseases: Can We Do Better?
Please see this review on Medicine Development, Pricing, and Access in the EU: Implications and Hurdles for Rare Diseases, with recommendations based on case to system approach at RARE-NL, and special attention for A Path Towards Socially Responsible Valorization.